Overview
Yelena Pristyazhnyuk is a Hematologist Oncology specialist and a Hematologist in Hartford, Connecticut. Dr. Pristyazhnyuk is rated as an Experienced provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Deep Vein Thrombosis, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
80 Seymour St, Hartford, CT 06102
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Umass Memorial Medical Group Inc
Doreen Brettler is a Hematologist Oncology specialist and a Hematologist in Worcester, Massachusetts. Dr. Brettler is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). Her top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Polycythemia Vera, and Essential Thrombocythemia.
Yale University
Kert Sabbath is a Hematologist Oncology specialist and a Hematologist in New Haven, Connecticut. Dr. Sabbath is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Lung Adenocarcinoma, and Angiosarcoma.
North Shore Hematology Oncology Associates PC
Ahmed Sawas is a Hematologist and a Hematologist Oncology provider in Port Jefferson Station, New York. Dr. Sawas is rated as a Distinguished provider by MediFind in the treatment of Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL). His top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Deep Vein ThrombosisDr. Pristyazhnyuk isAdvanced. Learn about Deep Vein Thrombosis.
- Hodgkin LymphomaDr. Pristyazhnyuk isAdvanced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaDr. Pristyazhnyuk isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Pristyazhnyuk isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Dr. Pristyazhnyuk isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Mountain SicknessDr. Pristyazhnyuk isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with MaturationDr. Pristyazhnyuk isExperienced. Learn about Acute Myeloblastic Leukemia with Maturation.
- Acute Myeloblastic Leukemia without MaturationDr. Pristyazhnyuk isExperienced. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Pristyazhnyuk isExperienced. Learn about Acute Myeloid Leukemia (AML).